FLGT — Fulgent Genetics, Inc.

—
Nasdaq · Health Care · Health Care Providers & Services · CIK 1674930 ·
Last close
$24.21
Market Cap
$676.40M
52W High
$31.04
52W Low
$13.46
ADV30
347,905
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 90,412,000 31,947,000 -22,547,000 -13,152,000 1,078,929,000 86,787,000 94,221,000
Jun 2026 85,389,000 25,679,000 -33,901,000 -29,530,000 1,089,223,000 26,305,000 93,237,000
Mar 2026 71,138,000 21,490,000 -34,622,000 -24,826,000 1,156,369,000 23,399,000 112,215,000
Dec 2025 83,336,000 32,582,000 -36,238,000 -23,418,000 1,213,525,000 50,193,000 106,810,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-83,697,000
Investing CF
$91,978,000
Financing CF
$-70,037,000
CapEx
$-20,090,000
Dividends Paid
—
Buybacks
$-69,221,000
EPS Diluted TTM
$-2.82
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$475,598,000
Inventory
$11,666,000
Receivables
$70,527,000
ST Investments
$230,727,000
EBIT TTM
$-92,331,000
Pretax Income TTM
$-92,451,000
Interest Exp TTM
$120,000
Analysts
1

Yahoo Snapshot (yfinance, live)

Total Revenue
$330,275,008
EBITDA
$-95,880,000
Free Cash Flow
$9,731,625
Enterprise Value
$375,121,856
Total Cash
$292,739,008
Total Debt
$10,370,000
Shares Out
27,939,000
Trailing EPS
$-3.10
Book Value
$35.68
ROE
-8.7%
ROA
-6.7%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 322,671,000 -91,096,000 -60,513,000 1,213,525,000 106,810,000 1,111,989,000 -101,638,000
Dec 2024 283,470,000 -73,918,000 -42,708,000 1,219,964,000 90,805,000 1,133,228,000 21,060,000
Dec 2023 289,213,000 -75,295,000 -167,825,000 1,235,328,000 102,042,000 1,136,101,000 27,003,000
Dec 2022 618,968,000 181,502,000 143,403,000 1,386,053,000 116,178,000 1,266,685,000 253,520,000

TTM Snapshot

Revenues TTM
$323,932,000
NetIncome TTM
$-84,382,000
OpCashFlow TTM
—
Assets (Latest)
$1,089,223,000
Forward EPS
$-1.38

Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)

max pain strike: $17.50 · spot: $25.13 · call volume: 53 · put volume: 9
Expected Move to 2027-01-15: ±$5.21 (20.73%) — implied range $19.92 – $30.34 · ATM straddle on $25.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
SBC SBC Medical Group Holdings Inc $629.42M $6.12 —
OMDA Omada Health, Inc. $872.90M $14.08 —
CSTL CASTLE BIOSCIENCES INC $1.02B $32.98 —
MCTA Charming Medical Ltd $445.55M $29.35 —
AHCO AdaptHealth Corp. $1.03B $7.53 —

News headlines (Yahoo Finance, 1h cache)

Fulgent Genetics (FLGT) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
2026-11-18 13:55 · Yahoo
Fulgent: 3 Key Takeaways for Long-Term Investors
2026-11-18 04:54 · Yahoo
Global Cardiovascular Genetic Testing Market Report 2026 | Capitalize on 11% CAGR and AI Genomics with Labcorp, Quest Diagnostics, Illumina, and Fulgent Genetics
2026-11-09 14:08 · Yahoo
Fulgent Genetics (FLGT) Q3 2026 Earnings Call Transcript
2026-11-06 17:33 · Yahoo
Fulgent Genetics, Inc. Q3 2026 Earnings Call Summary
2026-11-06 13:30 · Yahoo
Fulgent Genetics Inc (FLGT) Q3 2026 Earnings Call Highlights: Revenue Climbs 8% as Anatomic ...
2026-11-06 05:26 · Yahoo
What Fulgent Genetics (FLGT) Said on Its Q3 Earnings Call
2026-11-06 02:14 · Yahoo
Fulgent Genetics, Inc. (FLGT) Reports Q3 Loss, Beats Revenue Estimates
2026-11-06 00:00 · Yahoo
Fulgent to Announce Third Quarter 2026 Financial Results on Thursday, November 5, 2026
2026-10-15 20:05 · Yahoo
Fulgent Genetics (FLGT) Q2 2026 Earnings Call Transcript
2026-08-08 02:14 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.